Oxytocin Spray For Sale

Sourcing Research-Grade Oxytocin Spray for Laboratory Use

PX1 Research supplies high-purity oxytocin for laboratory research use only. Designed for preclinical experimentation, our research-grade oxytocin formulations undergo rigorous lot-specific RP-HPLC purity verification, mass spectrometry analysis, and endotoxin testing to ensure consistent neuroendocrine assay performance in non-human models.

When purchasing compounds for institutional or academic research, identifying reliable suppliers that guarantee structural integrity and lot-to-lot consistency is essential. Researchers investigating neuropeptide dynamics can explore our complete catalog of research peptides to access detailed technical specifications and lot-specific analytical data.

Biochemical Properties and Receptor Binding Mechanics of Oxytocin

Oxytocin is a nonapeptide hormone (C43H66N12O12S2) characterized by a cyclic structure formed by a disulfide bridge between cysteine residues at positions 1 and 6, along with a tripeptide C-terminal tail. In preclinical models, oxytocin acts primarily through the oxytocin receptor (OXTR), a class A G-protein-coupled receptor (GPCR) expressed throughout the central nervous system and peripheral tissues.

In vitro binding assays demonstrate that ligand binding to OXTR activates the Gq/11 signaling pathway, stimulating phospholipase C-beta (PLC-β) activity. This cascade induces the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG), causing a rapid mobilization of intracellular calcium ions (Ca2+). In cell culture models, this intracellular signaling pathway modulates synaptic plasticity, gene expression, and membrane excitability.

Researchers seeking to investigate these pathways rely on high-purity oxytocin peptide formulations that retain structural stability and functional binding affinity without interference from synthesis side-products or residual trifluoroacetic acid (TFA).

Preclinical Research Applications in Neurobiology and Physiology

In preclinical rodent models, central administration of oxytocin has been widely utilized to evaluate behavioral endocrinology, social recognition memory, anxiety-like behaviors, and stress axis regulation. Animal studies demonstrate that oxytocin signaling within the central nucleus of the amygdala and the paraventricular nucleus (PVN) of the hypothalamus modulates the hypothalamic-pituitary-adrenal (HPA) axis, attenuation of corticosterone release, and modification of fear conditioning responses.

Additionally, non-human primate research utilizes oxytocin formulations to study complex social dynamics, eye-gaze tracking, and neural connectivity via functional magnetic resonance imaging (fMRI). These preclinical trials provide crucial insights into how central oxytocinergic pathways interact with serotonergic, dopaminergic, and GABAergic systems.

To examine comprehensive data on central nervous system targets, investigators can reference the PX1 research portal, which details analytical standards and receptor interaction profiles for various signaling molecules.

Intranasal Delivery Mechanics in Rodent and Non-Human Primate Models

The introduction of intranasal oxytocin spray formulations in laboratory research offers a non-invasive mechanism to bypass the blood-brain barrier (BBB). Preclinical literature indicates that intranasally administered neuropeptides utilize mucosal transport pathways along the olfactory and trigeminal nerve branches to achieve direct central nervous system access.

In animal models, intranasal delivery minimizes systemic enzymatic degradation while delivering measurable concentrations of peptide to the olfactory bulb, brainstem, hippocampus, and cerebral cortex. Quantification of CSF concentrations post-administration confirms enhanced central bioavailability compared to standard peripheral intravenous or subcutaneous routes.

Proper research protocols require precise calibration of droplet size, solution pH, and osmolarity to ensure reproducible mucosal absorption and consistent dosing per spray actuator in laboratory setups.

Comparative Analysis: Oxytocin and Related Neuropeptides

When designing neurobehavioral or endocrine studies, researchers frequently compare oxytocin against other central-acting peptide regulators. For example, Selank is a synthetic heptapeptide derivative of tuftsin studied for its modulating effects on the GABAergic system and neurotrophic factor expression, whereas Semax targets ACTH-related pathways and BDNF expression to evaluate cognitive processing and neuroprotection. Additionally, arginine vasopressin (AVP) shares high structural homology with oxytocin, differing by only two amino acids, yet it preferentially acts on V1a, V1b, and V2 receptors to mediate vascular tone and distinct social-dominant behaviors.

Evaluating these distinct mechanisms allows laboratory teams to select the exact peptide profile required for targeted receptor mapping. Laboratories scaling up multi-peptide comparative screens can apply for bulk laboratory supply accounts to streamline procurement and retain consistent batch controls across extensive experimental runs.

Analytical Quality Verification: RP-HPLC, Mass Spectrometry, and Endotoxin Testing

Experimental reproducibility hinges upon compound purity. Low-quality peptides containing deletion sequences, truncated fragments, or heavy metal contaminants introduce confounding variables that compromise in vitro and in vivo assays. PX1 Research adheres to stringent quality control parameters across every manufactured batch.

Each lot undergoes Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to establish chemical purity, ensuring target peptide concentrations exceed 98%. Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF) is conducted concurrently to confirm the precise molecular mass and sequence integrity.

Furthermore, because bacterial endotoxins (lipopolysaccharides) alter immune responses and neural activity in preclinical models, PX1 Research subjects all peptides to rigorous endotoxin testing. Every shipment includes a lot-specific Certificate of Analysis (COA) issued by an independent ISO 17025 accredited laboratory.

Reconstitution, Handling, and Storage Guidelines for Laboratory Peptides

Maintaining peptide stability requires strict adherence to cold-chain storage and proper reconstitution techniques within the laboratory environment:

1. Temperature Management: Lyophilized oxytocin powder should be stored at -20°C or -80°C upon receipt to prevent thermal degradation over extended periods.

2. Reconstitution Protocol: Allow the peptide vial to equilibrate to room temperature before adding sterile bacteriostatic water or target buffer solutions. Gently swirl the container to dissolve the lyophilizate; avoid vigorous vortexing, which can disrupt delicate peptide disulfide bonds.

3. Aliquoting and Storage: Once reconstituted into liquid or spray formulations, divide the solution into single-use laboratory aliquots to avoid repeated freeze-thaw cycles. Liquid solutions should be stored at 2°C to 8°C for short-term experimentation or frozen at -80°C for longer storage intervals.

For additional handling parameters regarding neuropeptides, consult our technical library on oxytocin neurobiology research.

USA Manufacturing Standards and Supply Chain Integrity

PX1 Research manufactures peptides in state-of-the-art, GMP-compliant facilities located within the United States. Domestic production ensures strict adherence to quality management systems and eliminates the risks of degradation associated with prolonged international transit.

To ensure seamless project timelines for academic and clinical research facilities, orders processed Monday through Friday ship same-day directly from our distribution hubs in California and Arizona. Every order features fully traceable batch tracking to guarantee supply chain transparency from synthesis to laboratory bench.